The Neuro-Optometric Rehabilitation Association (NORA) has named Barbara Barclay, a recognized leader in eye-tracking technology and health tech, as its new executive director effective October 1, 2024. Barclay’s extensive 30-year career includes serving as president of RightEye and North American general manager for Tobii, where she introduced innovative eye-tracking technologies for conditions like brain injuries, reading delays, and Parkinson’s disease. She also held leadership roles at LexisNexis, Comscore, and Nielsen.
Dr. Charles Shidlofsky, NORA President, said, “Barbara brings a deep understanding of our community, including experience introducing eye-tracking technologies to improve assessments for conditions such as brain injuries, reading delays, and Parkinson’s disease.” He added that her expertise will support NORA’s mission to expand neuro-optometric rehabilitation services and interdisciplinary collaboration in health care.
Barclay succeeds Gary Esterow, who retired after six years of leading NORA through critical growth phases and the adoption of new interdisciplinary strategies for neurorehabilitation.
Barclay is excited about the opportunity, stating, “I am thrilled to join NORA and work alongside the board of directors and members to further the education of optometrists and others in neuro-optometric care. Together, we’ll continue to provide individuals and caregivers with the resources and tools they need to achieve optimal visual rehabilitation.”
Her leadership signals a continued commitment to innovation within neurorehabilitation, with Barclay set to advance NORA’s mission of raising awareness, expanding interdisciplinary approaches, and promoting visual rehabilitation techniques.
The Neuro-Optometric Rehabilitation Association, International is a global organization dedicated to advancing the rehabilitation of individuals with visual-motor and visual-perceptual dysfunction due to acquired brain injuries. NORA focuses on providing education and services to enhance ocular health and improve the quality of life for those affected by neurological conditions.